Midlothian, United Kingdom

Ian Wilmut

This inventor holds 17 USPTO granted patents and 1 published patent application, primarily in Nuclear Transfer Technology. Top assignees: Roslin Institute (Edinburgh), Roslin Institute, Biotechnology & Biological Sciences Research Council. Active years: 2000-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Wilmut. Retrieved from https://idiyas.com/inventor/ian-wilmut

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 35.3

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 125(Granted Patents)


Company Filing History:


Years Active: 2000-2009

Loading Chart...
Areas of Expertise:
Nuclear Transfer
Ungulates
Cloning
Cell Culture
Oocytes
Transgenic
Embryos
Quiescent Cells
Inner Cell Mass
Cytoplast
Methods
17 patents (USPTO):Explore Patents

Title: Ian Wilmut: Pioneering the Future of Biotechnology

Introduction

Ian Wilmut, a renowned inventor based in Midlothian, GB, is best known for his groundbreaking contributions to biotechnology, particularly in the field of cloning and animal reproduction. With a notable portfolio of 17 patents, Wilmut has been instrumental in advancing scientific understanding and applications of mammalian embryonic development.

Latest Patents

Among his latest patents, Wilmut developed methods focused on mammalian embryo reconstitution, which have the potential to revolutionize the production of transgenic animals. His patent titled "Mammalian cultured inner cell mass cell culture using a G1 cell as nuclear donor" describes a method where a diploid nucleus is transferred into an oocyte arrested in the second meiotic division. This innovative approach allows the donor nucleus to be kept exposed to recipient cytoplasm, which can later lead to live animal births. Another significant patent, "Mammalian cultured inner cell mass cell culture using a quiescent cell as nuclear donor," details a method utilizing a quiescent donor cell, providing great promise in generating animals of high genetic merit, both transgenic and non-transgenic.

Career Highlights

Ian Wilmut's career is marked by his association with the prestigious Roslin Institute in Edinburgh, where he made significant advancements in stem cell research and animal cloning. His work has received global recognition, particularly due to the successful cloning of Dolly the Sheep in 1996, which marked a monumental milestone in genetic engineering and sparked extensive discussions on cloning ethics and capabilities.

Collaborations

Throughout his career, Wilmut has collaborated with notable individuals in the field, such as Keith Henry Stockman Campbell, his partner in pioneering research initiatives at the Roslin Institute. Their teamwork has been vital in translating scientific theories into practical applications that have enhanced agricultural biotechnology and genetic research.

Conclusion

Ian Wilmut stands as a transformative figure in the realm of biotechnology and genetics. His innovative patents and collaborative efforts have laid the groundwork for new frontiers in science, particularly in cloning and animal production. Through his work, he continues to inspire a new generation of scientists and inventors, contributing to advancements that hold immense potential for both agricultural and medical fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…